New Delhi: The subject expert committee of the national drug regulator on Tuesday cleared Covaxin Covid-19 shot for emergency use in children aged 2 to 18 years, giving India the first approved vaccine for use in kids as young as 2 years.
The recommendations have been forwarded to the Drug Controller General of India (DCGI) for final approval.
Previously, the DCGI had cleared Ahmedabad-based Zydus Cadila’s ZyCoV-D for emergency use in people aged 12 years and above. The clearance to vax for children between 2 to 18 years comes at a time when schools are reopening amid fears of the disease impacting children.